Crossmark

Cost comparison of andexanet versus prothrombin complex concentrates for direct factor Xa inhibitor reversal after hemorrhage

Published Online: 2019-10-29

Published Print: 2020-01

Authors

Frontera, Jennifer A.

Bhatt, Prachi

Lalchan, Rebecca

Yaghi, Shadi

Ahuja, Tania

Papadopoulos, John

Joset, Danielle
License Information

Text and Data Mining valid from 2019-10-29

Version of Record valid from 2019-10-29
More Information

Article History

First Online: 29 October 2019

Compliance with ethical standards

:

: The authors have nothing to disclose.

Document is current